Orally -Bioavailable Androgen Receptor Degrader: Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer

Suriyan Ponnusamy, Yali He, Dong-Jin Hwang, Thirumagal Thiyagarajan, Rene Houtman, Vera Bocharova, Bobby G. Sumpter, Elias Fernandez, Daniel Johnson, Ziyun Du, Lawrence M. Pfeffer, Robert H. Getzenberg, Iain J. McEwan, Duane D. Miller, Ramesh Narayanan* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticle

6 Citations (Scopus)

Fingerprint Dive into the research topics of 'Orally -Bioavailable Androgen Receptor Degrader: Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences